Grace Therapeutics Inc
For the period ended Mar 31, 2025. Filed Jun 23, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jun 23, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GRACE THERAPEUTICS, INC. | |
| By: | /s/ Prashant Kohli |
| Name: | Prashant Kohli |
| Title: Chief Executive Officer and | |
| (Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Prashant Kohli | Chief Executive Officer | June 23, 2025 |
| Prashant Kohli | (Principal Executive Officer) | |
| /s/ Robert DelAversano | Principal Financial Officer | June 23, 2025 |
| Robert DelAversano | (Principal Financial Officer and Principal Accounting Officer) | |
| /s/ Brian Davis | Director | June 23, 2025 |
| Brian Davis | ||
| /s/ Vimal Kavuru | Director | June 23, 2025 |
| Vimal Kavuru | ||
| /s/ Edward Neugeboren | Director | June 23, 2025 |
| Edward Neugeboren | ||
| /s/ George Kottayil | Director | June 23, 2025 |
|---|---|---|
| George Kottayil | ||
For the years ended March 31, 2025 and 2024
| Report of Independent Registered Public Accounting Firm (PCAOB 185) | F-1 |
|---|---|
| Consolidated Balance Sheets | F-2 |
| Consolidated Statements of Loss and Comprehensive Loss | F-3 |
| Consolidated Statements of Stockholders’ Equity | F-4 |
| Consolidated Statements of Cash Flows | F-5 |
| Notes to the Consolidated Financial Statements | F-6 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.